TERT-BUTYLAZANIUM;(E,3R,5S)-7-(4-(4-FLUOROPHENYL)-2-(METHYL(METHYLSULFONYL)AMINO)-6-PROPAN-2-YLPYRIMIDIN-5-YL)-3,5-DIHYDROXYHEPT-6-ENOATE
UNII D4M5V2K6E9

Substance Identification & Data

This profile provides standardized clinical and technical data for Tert-butylazanium;(e,3r,5s)-7-(4-(4-fluorophenyl)-2-(methyl(methylsulfonyl)amino)-6-propan-2-ylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D4M5V2K6E9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 917805-74-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
D4M5V2K6E9
CAS Registry Number
917805-74-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TERT-BUTYLAZANIUM;(E,3R,5S)-7-(4-(4-FLUOROPHENYL)-2-(METHYL(METHYLSULFONYL)AMINO)-6-PROPAN-2-YLPYRIMIDIN-5-YL)-3,5-DIHYDROXYHEPT-6-ENOATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C22H28FN3O6S.C4H11N
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
OBQRUQWCSRLLAM-DHMAKVBVSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1(nc(c(c(C(C)C)n1)/C=C/[C@H](C[C@@H](O)CC(O)=O)O)-c2ccc(cc2)F)N(C)S(C)(=O)=O.NC(C)(C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tert-butylazanium;(e,3r,5s)-7-(4-(4-fluorophenyl)-2-(methyl(methylsulfonyl)amino)-6-propan-2-ylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(3R,5S,6E)-7-(4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-2-(METHYL(METHYLSULFONYL)AMINO)-5-PYRIMIDINYL)-3,5-DIHYDROXY-6-HEPTENOIC ACID, 2-METHYL-2-PROPANAMINE (1:1)
6-HEPTENOIC ACID, 7-(4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-2-(METHYL(METHYLSULFONYL)AMINO)-5-PYRIMIDINYL)-3,5-DIHYDROXY-, (3R,5S,6E)-, COMPD. WITH 2-METHYL-2-PROPANAMINE (1:1)
TERT-BUTYLAZANIUM;(E,3R,5S)-7-(4-(4-FLUOROPHENYL)-2-(METHYL(METHYLSULFONYL)AMINO)-6-PROPAN-2-YLPYRIMIDIN-5-YL)-3,5-DIHYDROXYHEPT-6-ENOATE